Patients with HIV who are resistant to all four antiretroviral drug classes face a higher risk for death than those who are ...

His study showed that around 5 percent of HIV-infected children who receive antiretrovirals within the first six months of ...

Evidence is growing that some HIV-infected infants, if given antiretroviral drugs early in life, are able to suppress their ...

With Black women and straight men increasingly at risk, Gilead’s Yeztugo may finally offer a discreet, stigma-free way to ...

Recent developments in antiretroviral therapy (ART) include longer-acting therapies that don't require a daily oral pill and ...

Gilead Sciences on Thursday reported flat second-quarter earnings on slightly higher revenue and raised its full-year ...

Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given.

Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...

In Kenya, HIV funding from the U.S. in fiscal year 2024 totaled $307.9 million, equivalent to almost a third of the country’s ...

I was sent to different posts, and one of the rooms was for the HIV testing,” says a woman we spoke with during a visit to the clinic last week. “I guess it’s a good thing, but they have to explain ...

Cases of human immunodeficiency virus (HIV) in Pangasinan is rising. From January to July this year, the province has ...

Advances in medicine mean more people are living longer with HIV. But aging with HIV comes with increased health risks, and this growing population needs specialized care that's hard to find.